Innoviva, Inc.
INVABiotechnology
$21.31+0.90%As of Oct 29vs prior close
- Market cap
- $1.5B
- P/E (TTM)
- 4.2×
- P/E (FY1)
- 11.2×
- From 52W high
- −12.09%
- EPS (LTM)
- $4.35
- Revenue (LTM)
- $440M
- Net margin
- 81.19%
Nomior Score
73
Fortified DefenderTop 6% of the scored universe
Growth51
Quality73
Value63
Momentum66
Resilience68
Growth
+13.31%revenue a year over 9 fiscal years
YE16 $133.6MLTM $440M
Connections
Revenue to profitQ2 YE26
The net loss was 70% of revenue, wider by 133 pts on a year.
Who owns it
2funds